About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

222. Primary nephrotic syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 576 / Drugs : 519 - (DrugBank : 130) / Drug target genes : 108 - Drug target pathways : 219

Other names

Nephrotic syndrome;Glomerulonephritis;

Disease group

Kidney and urinary diseases

Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese)

14,333 patients

Age distribution

💬

Clinical research form (in Japanese)
MHLW Intractable Diseases, FY2026 (in Japanese)

Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf)

Specific pediatric chronic diseases, Japan (in Japanese)

2-1-1. Congenital nephrotic syndrome of the Finnish type; CNF

2-1-2. Diffuse mesangial sclerosis; DMS

2-1-7. Other nephrotic syndromes

Sub-diseases
(Clinical research forms may not be available for all sub-diseases.)

No.

Name

Specific pediatric chronic diseases, Japan (in Japanese)

222-1.

Minimal change nephrotic syndrome;MCNS;

2-1-3. Minimal change nephrotic syndrome; MCNS

222-2.

Membranous nephropathy;

2-1-5. Membranous nephropathy

222-3.

Focal segmental glomerulosclerosis;FSGS;

2-1-4. Focal segmental glomerulosclerosis; FSGS

222-4.

Crescentic glomerulonephritis;CGN;CrGN;

222-5.

Endocapillary proliferative glomerulonephritis;